Epoch Biodesign Ltd
- Company number
- 11824812
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 13 Feb 2019
- Nature of business
- Research and experimental development on biotechnology
Registered office
Previous names
- Mellizyme Biotechnology Limited (until 15 Feb 2023)
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dr Douglas Bruce Kell | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
13 Feb 2019 | 10 Oct 2023 |
| Mr Jacob Leon Nathan | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
13 Feb 2019 | 13 Nov 2024 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Mar 2025 | £13,474,994 | £11,571,182 | 0 |
| 31 Mar 2024 | - | £2,035,215 | 17 |
| 31 Mar 2023 | - | £4,926,947 | 12 |
| 31 Mar 2022 | - | £8,533,695 | 4 |
| 31 Mar 2021 | £2,486,724 | £2,128,357 | 4 |
| 31 Mar 2020 | -£37,060 | £136,784 | 0 |
Connections
Companies at the same address
- Hkex Global Commodities Limited (08078934)
- LME Clear Limited (07611628)
- LME Holdings Limited (04081219)
- The London Metal Exchange (02128666)